Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20034276HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034277HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034280HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047208HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034278HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034282HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034283HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047211HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047209HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034281HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TCGA Plot Options
Drug Information
GeneHTR1D
DrugBank IDDB01200
Drug NameBromocriptine
Target IDBE0000659
UniProt IDP28221
Regulation Typeagonist
PubMed IDs18691132; 10641988
CitationsKvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67.@@Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S.
GroupsApproved; Investigational; Withdrawn
Direct ClassificationLysergamides
SMILES[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Pathways
PharmGKBPA448671
ChEMBLCHEMBL493